Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBasic Science Investigations

The Somatostatin Analog 188Re-P2045 Inhibits the Growth of AR42J Pancreatic Tumor Xenografts

Carol A. Nelson, Michael T. Azure, Christopher T. Adams and Kurt R. Zinn
Journal of Nuclear Medicine December 2014, 55 (12) 2020-2025; DOI: https://doi.org/10.2967/jnumed.114.140780
Carol A. Nelson
1Translational Medicine Consulting, Westford, Massachusetts
2Department of Research and Development, Andarix Pharmaceuticals, Watertown, Massachusetts; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael T. Azure
3Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher T. Adams
2Department of Research and Development, Andarix Pharmaceuticals, Watertown, Massachusetts; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kurt R. Zinn
3Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 55 no. 12 2020-2025
DOI 
https://doi.org/10.2967/jnumed.114.140780
PubMed 
25359879

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication April 13, 2014
  • Accepted for publication September 11, 2014
  • Published online December 1, 2014.

Article Versions

  • previous version (October 30, 2014 - 05:24).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Carol A. Nelson1,2,
  2. Michael T. Azure3,
  3. Christopher T. Adams2 and
  4. Kurt R. Zinn3
  1. 1Translational Medicine Consulting, Westford, Massachusetts
  2. 2Department of Research and Development, Andarix Pharmaceuticals, Watertown, Massachusetts; and
  3. 3Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama
  1. For correspondence or reprints contact: Carol A. Nelson, Andarix Pharmaceuticals and Translational Medicine Consulting, 18 Maple St., Westford, MA 01886. E-mail: pharmacologyconsultants{at}gmail.com
View Full Text

Statistics from Altmetric.com

Cited By...

  • 5 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy
    Romain Eychenne, Christelle Bouvry, Mickael Bourgeois, Pascal Loyer, Eric Benoist, Nicolas Lepareur
    Molecules 2020 25 17
  • Validation of an automatic reference region extraction for the quantification of [18F]DPA-714 in dynamic brain PET studies
    Daniel García-Lorenzo, Sonia Lavisse, Claire Leroy, Catriona Wimberley, Benedetta Bodini, Philippe Remy, Mattia Veronese, Federico Turkheimer, Bruno Stankoff, Michel Bottlaender
    Journal of Cerebral Blood Flow & Metabolism 2018 38 2
  • Synthetic Receptor-Based Targeting Strategies to Improve Tumor Drug Delivery
    Susheel Kumar Nethi, Shubhmita Bhatnagar, Swayam Prabha
    AAPS PharmSciTech 2021 22 3
  • Combining [177Lu]Lu-DOTA-TOC PRRT with PARP inhibitors to enhance treatment efficacy in small cell lung cancer
    Hartmut Rauch, Carolin Kitzberger, Kirti Janghu, Pavithra Hawarihewa, Nghia T. Nguyen, Yu Min, Simone Ballke, Katja Steiger, Wolfgang A. Weber, Susanne Kossatz
    European Journal of Nuclear Medicine and Molecular Imaging 2024 51 13
  • Determination of the Re-188 Calibration Number for the Capintec CRC- 25PET Dose Calibrator
    Mitchell Ashley Klenner, Aron Poole
    Current Radiopharmaceuticals 2023 16 4

Article usage

Article usage: October 2014 to April 2025

AbstractFullPdf
Oct 20146109
Nov 2014282044
Dec 20146062254
Jan 20151781425
Feb 201577913
Mar 2015108714
Apr 201584118
May 201550910
Jun 201547911
Jul 2015351830
Aug 2015441111
Sep 2015711812
Oct 2015261911
Nov 2015581122
Dec 201544117
Jan 2016561217
Feb 201638511
Mar 2016251117
Apr 201621618
May 201626626
Jun 201627211
Jul 201611720
Aug 201615616
Sep 201619612
Oct 2016211214
Nov 2016221016
Dec 201620109
Jan 20172286
Feb 2017231816
Mar 20172562
Apr 20171258
May 201722713
Jun 201714127
Jul 20171297
Aug 201714155
Sep 2017764
Oct 201710129
Nov 20172576
Dec 20171884
Jan 2018999
Feb 20181285
Mar 2018833
Apr 20181365
May 20181036
Jun 2018801
Jul 2018841
Aug 20181111
Sep 2018672
Oct 2018465
Nov 20181012
Dec 2018434
Jan 20197810
Feb 2019239
Mar 20195310
Apr 2019899
May 2019131210
Jun 20196115
Jul 20191539
Aug 2019588
Sep 2019647
Oct 2019936
Nov 2019825
Dec 2019943
Jan 202011116
Feb 2020437
Mar 20208610
Apr 2020648
May 20204911
Jun 2020613
Jul 2020347
Aug 2020549
Sep 2020538
Oct 20202327
Nov 202013712
Dec 2020287
Jan 20213821
Feb 202182624
Mar 20212198
Apr 20213114
May 202162312
Jun 20216176
Jul 202151117
Aug 2021101017
Sep 20216149
Oct 202151222
Nov 202151229
Dec 202182413
Jan 20225119
Feb 20227137
Mar 202231011
Apr 2022378
May 202221424
Jun 202242530
Jul 20226176
Aug 202231312
Sep 20227817
Oct 20222610
Nov 2022063
Dec 202210169
Jan 20232810
Feb 20231153
Mar 20232128
Apr 20233142
May 202381415
Jun 2023773
Jul 202331622
Aug 20232220
Sep 20231619
Oct 202332310
Nov 202334212
Dec 20231688
Jan 20243268
Feb 20246158
Mar 202401830
Apr 202449817
May 202442010
Jun 202452114
Jul 202452418
Aug 2024222913
Sep 2024141218
Oct 202461311
Nov 20241810
Dec 20240259
Jan 202561932
Feb 2025175925
Mar 202553827
Apr 2025172834
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 55 (12)
Journal of Nuclear Medicine
Vol. 55, Issue 12
December 1, 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Somatostatin Analog 188Re-P2045 Inhibits the Growth of AR42J Pancreatic Tumor Xenografts
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The Somatostatin Analog 188Re-P2045 Inhibits the Growth of AR42J Pancreatic Tumor Xenografts
Carol A. Nelson, Michael T. Azure, Christopher T. Adams, Kurt R. Zinn
Journal of Nuclear Medicine Dec 2014, 55 (12) 2020-2025; DOI: 10.2967/jnumed.114.140780

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Somatostatin Analog 188Re-P2045 Inhibits the Growth of AR42J Pancreatic Tumor Xenografts
Carol A. Nelson, Michael T. Azure, Christopher T. Adams, Kurt R. Zinn
Journal of Nuclear Medicine Dec 2014, 55 (12) 2020-2025; DOI: 10.2967/jnumed.114.140780
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer
  • Tumor-Specific Binding of Radiolabeled PEGylated GIRLRG Peptide: A Novel Agent for Targeting Cancers
  • PET/MRI of Hypoxic Atherosclerosis Using 64Cu-ATSM in a Rabbit Model
Show more Basic Science Investigations

Similar Articles

Keywords

  • somatostatin
  • AR42J pancreatic tumor
  • radiotherapeutic
  • neuroendocrine
  • pancreas
SNMMI

© 2025 SNMMI

Powered by HighWire